163 related articles for article (PubMed ID: 2696637)
1. Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl)phthalate.
Conway JG; Cattley RC; Popp JA; Butterworth BE
Drug Metab Rev; 1989; 21(1):65-102. PubMed ID: 2696637
[No Abstract] [Full Text] [Related]
2. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
Marsman DS; Cattley RC; Conway JG; Popp JA
Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084
[TBL] [Abstract][Full Text] [Related]
3. Species differences in di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation.
Lake BG; Gray TJ; Foster JR; Stubberfield CR; Gangolli SD
Dev Toxicol Environ Sci; 1983; 11():595-8. PubMed ID: 6677511
[No Abstract] [Full Text] [Related]
4. Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate for 2 years.
Cattley RC; Conway JG; Popp JA
Cancer Lett; 1987 Dec; 38(1-2):15-22. PubMed ID: 3690505
[TBL] [Abstract][Full Text] [Related]
5. Di-n-octyl phthalate (DOP), a relatively ineffective peroxisome inducing straight chain isomer of the environmental contaminant di(2-ethylhexyl)phthalate (DEHP), enhances the development of putative preneoplastic lesions in rat liver.
DeAngelo AB; Garrett CT; Manolukas LA; Yario T
Toxicology; 1986 Nov; 41(3):279-88. PubMed ID: 2877511
[TBL] [Abstract][Full Text] [Related]
6. Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats following short-term exposure to the peroxisome proliferators di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate.
Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y
Jpn J Cancer Res; 1990 Mar; 81(3):213-5. PubMed ID: 2112523
[TBL] [Abstract][Full Text] [Related]
7. Comment on the carcinogenic potential of di(2-ethylhexyl) phthalate.
Northup S; Martis L; Ulbricht R; Garber J; Miripol J; Schmitz T
J Toxicol Environ Health; 1982 Sep; 10(3):493-518. PubMed ID: 7175976
[TBL] [Abstract][Full Text] [Related]
8. Lack of hepatic promotional activity by the peroxisomal proliferating hepatocarcinogen di(2-ethylhexyl)phthalate.
Popp JA; Garvey LK; Hamm TE; Swenberg JA
Carcinogenesis; 1985 Jan; 6(1):141-4. PubMed ID: 2857115
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of hepatocellular lesions induced by di(2-ethylhexyl)phthalate in F-344 rats.
Rao MS; Yeldandi AV; Subbarao V
J Toxicol Environ Health; 1990 Jun; 30(2):85-9. PubMed ID: 2355402
[TBL] [Abstract][Full Text] [Related]
10. Di(2-ethylhexyl) phthalate.
IARC Monogr Eval Carcinog Risk Chem Hum; 1982 May; 29():269-94. PubMed ID: 6751991
[No Abstract] [Full Text] [Related]
11. Absence of gamma-glutamyl transpeptidase activity in neoplastic lesions induced in the liver of male F-344 rats by di-(2-ethylhexyl)phthalate, a peroxisome proliferator.
Rao MS; Usuda N; Subbarao V; Reddy JK
Carcinogenesis; 1987 Sep; 8(9):1347-50. PubMed ID: 2887302
[TBL] [Abstract][Full Text] [Related]
12. Assessing human health risks from exposure to di(2-ethylhexyl)phthalate (DEHP) and related phthalates: scientific issues.
Schulz CO
Drug Metab Rev; 1989; 21(1):111-20. PubMed ID: 2696632
[No Abstract] [Full Text] [Related]
13. In vivo studies on the mechanism of di(2-ethylhexyl)phthalate carcinogenesis.
Popp JA; Garvey LK; Cattley RC
Toxicol Ind Health; 1987 Jun; 3(2):151-63. PubMed ID: 3303447
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.
Reddy JK; Reddy MK; Usman MI; Lalwani ND; Rao MS
Environ Health Perspect; 1986 Mar; 65():317-27. PubMed ID: 3709457
[TBL] [Abstract][Full Text] [Related]
15. A review of di(2-ethylhexyl)phthalate (DEHP) risk assessments.
Beliles R; Salinas JA; Kluwe WM
Drug Metab Rev; 1989; 21(1):3-12. PubMed ID: 2696634
[No Abstract] [Full Text] [Related]
16. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.
Conway JG; Tomaszewski KE; Olson MJ; Cattley RC; Marsman DS; Popp JA
Carcinogenesis; 1989 Mar; 10(3):513-9. PubMed ID: 2924396
[TBL] [Abstract][Full Text] [Related]
17. Modifying effects of butylated hydroxyanisole, di(2-ethylhexyl)phthalate or indomethacin on mouse hepatocarcinogenesis initiated by N-nitrosodiethylamine.
Hagiwara A; Diwan BA; Ward JM
Jpn J Cancer Res; 1986 Dec; 77(12):1215-21. PubMed ID: 3102426
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome induction studies on seven phthalate esters.
Barber ED; Astill BD; Moran EJ; Schneider BF; Gray TJ; Lake BG; Evans JG
Toxicol Ind Health; 1987 Jun; 3(2):7-24. PubMed ID: 3617071
[TBL] [Abstract][Full Text] [Related]
19. DEHP [Di(2-ethylhexyl)phthalate]--risk assessment. The EPA workshop. April 19-20, 1988, Bethesda, Maryland. Proceedings.
Drug Metab Rev; 1989; 21(1):1-120. PubMed ID: 2625122
[No Abstract] [Full Text] [Related]
20. Carcinogenic potential of phthalic acid esters and related compounds: structure-activity relationships.
Kluwe WM
Environ Health Perspect; 1986 Mar; 65():271-8. PubMed ID: 3709453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
